MAMichel Arock

Michel Arock

*This is an algorithmically generated author record based on publicly available information.

Michel Arock has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • C-kit and Mastocytosis

    by Frédéric Féger, Olivier Hermine, Jean-Jacques Guillosson, Michel Arock

  • Open Access

    c-Kit and c-kit mutations in mastocytosis and other hematological diseases

    by Mathieu Boissan, Frédéric Feger, Jean-Jacques Guillosson, Michel Arock

    Mast cells (MC) are tissue elements derived from hematopoietic stem cells. Their differentiation and proliferation processes are under the influence of cytokines, including one of utmost importance known as stem cell factor (SCF). SCF receptor is encoded by the protooncogene c‐kit, belongs to the type III receptor tyrosine kinase subfamily, and is also expressed on other hematopoietic or non‐hematopoietic cells. Ligation of c‐kit receptor by SCF induces its dimerization, followed by induction of multiple intracellular signaling pathways leading to cell proliferation and activation. Mastocytosis, a relatively rare group of diseases characterized by accumulation of MC in various tissues, are found isolated or sometimes associated with other hematological malignancies in humans. Although the initial events leading to mastocytosis are not yet unraveled, alterations of the c‐kit gene have been described. Particularly interesting are acquired mutations resulting in a constitutively activated receptor, possibly involved in the increased numbers of MC in tissues. For this reason, future strategies might be envisaged to target specifically the mutated c‐kit and/or its intracellular signaling. J. Leukoc. Biol. 67: 135–148; 2000.


  • Nitric oxide pathway is induced by FcεRI and up‐regulated by stem cell factor in mouse mast cells

    by Mohamed Bidri, Sandra Ktorza, Ioannis Vouldoukis, Liliane Le Goff, Patrice Debré, Jean‐Jacques Guillosson, Michel Arock

    Murine stem cell factor (SCF) induces the differentiation of mucosal mast cells (MMC) into connective tissue mast cells (CTMC) and potentiates mediator release induced by aggregation of high‐affinity IgE receptors (FcεRI). In the present work, we investigated the effect of FcεRI aggregation on nitric oxide (NO) pathway induction in the different subsets of mast cells, as well as the contribution of SCF in this induction. Inducible NO synthase (iNOs) expression was not evidenced in non‐stimulated MMC obtained by culture of hematopoietic progenitors in the presence of interleukin‐3, whereas IgE‐antigen‐stimulated MMC expressed iNOs mRNA and protein and synthesized nitrites. Long‐term treatment of MMC with SCF, allowing them to differentiate into CTMC, induced iNOs expression in non‐stimulated cells and up‐regulated iNOs expression and generation of NO derivatives induced by IgE‐antigen stimulation. Thus, NO derivatives generated by mast cells could participate in inflammatory reactions during allergic stimulation.


  • Open Access

    Inducible Nitric Oxide Synthase and Proinflammatory Cytokine Expression by Human Keratinocytes during Acute Urticaria

    by Pierre-André Bécherel, Olivier Chosidow, Liliane Le Goff, Camille Francès, Patrice Debré, M. Djavad Mossalayi, Michel Arock